Home/Clevexel Pharma/Christian Bloy
CB

Christian Bloy

CEO, Co-founder, and Board Member

Clevexel Pharma

Clevexel Pharma Pipeline

DrugIndicationPhase
CVXL-0095Reduction of mucositis or dermatitis induced by radiotherapy or chemotherapyPre-clinical / Phase 1
CVXL-0255Immuno-inflammatory diseases (via inhibition of SYK and JAK enzymes)Pre-clinical